or
Remember me
Back
Hello and Happy Friday,
To all our valued followers, friends, family and shareholders we are happy to deliver a weekly recap of our company news, media coverage and useful insights.
As you are all likely aware, on October 5, 2021 we opened trading on the TSX Venture Exchange under the ticker symbol IBO.
We had a huge first day, with over 2.2 million shares trading hands.
We welcomed in many new shareholders and said thank you and farewell to some of our early supporters. We thank you all for your support and faith in our mission.
We enjoyed some great coverage in the media with the following features:
BNN Bloomberg - Universal Ibogaine is Spearheading a New Approach to Addiction Treatment
Born 2 Invest - Canada's Hidden Health Crisis: Is this Company the Only One Paying Attention?
Belair Capital Advisors - Universal Ibogaine: State of the Art Plant Based Addiction Treatment
[paid promotional message] - Universal Ibogaine: Now Trading Under the Ticker IBO
We have begun the process of filing our OTC listing. For those who are not aware the OTC is a venture exchange platform in the USA. Adding an OTC listing will allow a huge market of hungry investors to access buying our shares. This increase in demand for our stock without any new supply should produce positive upward pressure on our valuation.
Thank you all for your support, we could not do this crucially important work without you.
Stay tuned for further updates.
Dr. Rami Batal
CEO
Universal Ibogaine Inc. 595 Howe Street Suite 303 Vancouver, British Columbia V6C2T5 Canada 1 (855) 426-4246